BMS highlights shift to biologics with plans for $900m plant in Ireland
Bristol-Myers Squibb has announced plans to build a biologics facility in Ireland, eight months after winding down a small molecule API plant at the same site.
Archives for November 14, 2014
AZ, ISIS expand partnership to develop novel delivery methods for antisense oligonucleotides
Isis Pharmaceuticals and AstraZeneca have expanded their partnership to develop novel delivery methods for antisense oligonucleotides in order to target the desired tissue more effectively.
GE sets up in Istanbul in bid to capture a share of Turkish tech market
Turkey’s efforts to increase local biopharmaceutical production have prompted GE Healthcare Life Sciences to set up a biopharmaceutical technology training centre in Istanbul.
WuXi plans commercial biomanufacturing plant on back of biologics demand
WuXi PharmaTech has reported a 23% growth in manufacturing services and is planning to build a commercial biomanufacturing facility to meet the strong demand for biologics.
EDITOR'S BLOG
'In space, no one can hear you sneeze,' say mythbusting virologists
There is no evidence that Ebola arrived on Earth from the stars, say a number of virologists, debunking media speculation that viruses had their origins in the Milky Way.